Cookie preferences
We use cookies, including third-party cookies, to collect information about how visitors use our website. The personal data we collect is used to tailor advertisements. Cookies are used to provide you with an optimal browsing experience, to continuously improve our site, and, with your consent, may be used by our partners to display personalised advertising by showing you offers tailored to your interests.

By clicking on the "Accept" button, you consent to the use of all cookies, including those used to personalise advertisements according to your interests. If you close this banner or continuing with essential cookies, only technical and analytical cookies will be used for which your consent is not required. You can revoke your consent to all or some cookies at any time by clicking on the "Cookie Preferences" button, also accessible from the footer of the site.

Detailed information on the use of cookies can be found in our privacy and cookie policy.

Difass obtains a new patent


On 29 of February 2024 Difass International has obtained with great pleasure and satisfaction a patent that protects the entire Dibuzin® formulation complex.

Patent’s title is: “COMPOSITIONS FOR THE TREATMENT OF DISEASES AND SYNDROMES RELATED TO INTESTINAL BARRIER DYSFUNCTION AND DYSBIOSIS’”

The patent with number 102022000003929 will last for 20 years from the filing date (02/03/2022 - 02/03/2042).

Obtaining this patent represents an added value in terms of the uniqueness of Dibuzin® product, confirming the company's strong orientation towards specialization and continuous innovation.


pageview